Actipulse Neuroscience is at the forefront of oncological innovation with its pioneering use of high-frequency low-intensity magnetic pulses to address one of the most challenging aspects of brain cancer treatment: drug delivery across the Blood-Brain Barrier (BBB). Our non-invasive technology, initially developed for psychiatric conditions, has been repurposed to increase BBB permeability transiently, allowing for more efficient and targeted delivery of chemotherapeutic agents to glioblastoma or neurodegenerative diseases.
